Skip to content

Public FDA record

Z-0113-2020: Achilles Express Bone Sonometer

Recall record Z-0113-2020 for GE Healthcare, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0113-2020
Company in FDA record
GE Healthcare, LLC
FDA record creation date
Oct 10, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Certain Achilles Express and Achilles Insight systems were shipped with European CEE-7/7 Type Power Cords to countries where three protruding pin plugs are required for protective earth connection.

Source facts

Action
GE Healthcare notified customers on about 09/03/2019, via "URGENT MEDICAL DEVICE CORRECTION" letter. Customers were informed of two (2) safety issues. The first safety issue was that certain Achilles Express and Achilles Insight systems were shipped with European CEE-7/7 Type Power Cords to countries where three protruding pin plugs are required for protective earth connection. This issue could lead to an electric shock. There have been no reported injuries as a result of this issue. Specific safety instructions included to continue using the system after following the below instructions: 1. Inspect the power cord set used on your Achilles Express or Achilles Insight system and ensure its compatibility with your wall socket; 2. Use the European CEE 7/7 Type plug only with the two wall sockets because the protective earthing connection will not be established with any other socket; 3. Do not use any adapters with your plug or wall socket; 4. If you have a CEE 7/7 Type plug and a wall socket other than that shown in Figure 2 of the letter, discontinue use of your system. Your power cord set will be replaced with the correct power cord. Destroy the incorrect power cord to ensure it is not used. The second safety issue is that certain Achilles Express and Achilles Insight systems were shipped with 125V rated power cords (type B plug) to these countries where the mains voltage could be greater than 200V. This issue could lead to an electric shock. There have been no reported injuries as a result of this issue. Specific safety instructions included, that for certain systems in Peru, Philippines and Thailand, a power cord type B plug rated at 125V, as shown in Figure 3, was shipped. The mains voltage in these countries could be greater than 200V and, as a result, this plug should not be used. If you are located in one of these three countries with mains voltage greater than 200V and have the plug shown in Figure 3 of the letter, disconnect your Achil
Initiated
2019-09-03
Root cause
Device Design
Terminated
2021-02-16
Distribution
Nationwide distribution to AZ, GA, MT, NC, NJ, NY, OH, WI. International distribution to Australia, Bahrain, Bangladesh, Brazil, Cambodia, Chile, China, Colombia, Cyprus, Hong Kong, India, Iraq, Ireland, Italy, Kuwait, Lebanon, Malaysia, Mauritius, Mexico, MEXICO, Myanmar, Nepal, Oman, Panama, Peru, Philippines, Saudi Arabia, Singapore, Sri Lanka, Switzerland, Taiwan, Thailand, United Arab Emirates, United Kingdom, Uruguay, Vietnam
Recall number
Z-0113-2020
Recall status
Terminated
CDRH record ID
176408
FDA record created
2019-10-10
Recall event number
83811

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗